Thomas Wilson Eastling - Net Worth and Insider Trading

Thomas Wilson Eastling Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Thomas Wilson Eastling owns 1 companies in total, including Catalyst Biosciences Inc (CBIO) .

Click here to see the complete history of Thomas Wilson Eastling’s form 4 insider trades.

Insider Ownership Summary of Thomas Wilson Eastling

Ticker Comapny Transaction Date Type of Owner
CBIO Catalyst Biosciences Inc 2022-12-26 director

Thomas Wilson Eastling Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Thomas Wilson Eastling Ownership Network

Ownership Network List of Thomas Wilson Eastling

No Data

Ownership Network Relation of Thomas Wilson Eastling

Insider Network Chart

Thomas Wilson Eastling Owned Company Details

What does Catalyst Biosciences Inc do?

Who are the key executives at Catalyst Biosciences Inc?

Thomas Wilson Eastling is the director of Catalyst Biosciences Inc. Other key executives at Catalyst Biosciences Inc include director & Chief Executive Officer Charles C Wu , director & President Songjiang Ma , and Chief Operating Officer Weiguo Ye .

Catalyst Biosciences Inc (CBIO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Catalyst Biosciences Inc (CBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Catalyst Biosciences Inc (CBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Catalyst Biosciences Inc (CBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Catalyst Biosciences Inc Insider Transactions

No Available Data

Thomas Wilson Eastling Mailing Address

Above is the net worth, insider trading, and ownership report for Thomas Wilson Eastling. You might contact Thomas Wilson Eastling via mailing address: 17520 High Bluff Drive, Suite 250, San Diego Ca 92130.